Connection

Michael Diamond to Mice

This is a "connection" page, showing publications Michael Diamond has written about Mice.
Connection Strength

1.698
  1. An Immunocompetent Mouse Model of Zika Virus Infection. Cell Host Microbe. 2018 05 09; 23(5):672-685.e6.
    View in: PubMed
    Score: 0.179
  2. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep. 2021 07 27; 36(4):109452.
    View in: PubMed
    Score: 0.056
  3. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host Microbe. 2021 07 14; 29(7):1151-1161.e5.
    View in: PubMed
    Score: 0.056
  4. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
    View in: PubMed
    Score: 0.056
  5. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.054
  6. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 2021 04 01; 184(7):1804-1820.e16.
    View in: PubMed
    Score: 0.054
  7. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020 11; 21(11):1327-1335.
    View in: PubMed
    Score: 0.053
  8. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020 10 01; 183(1):169-184.e13.
    View in: PubMed
    Score: 0.052
  9. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host Microbe. 2020 09 09; 28(3):465-474.e4.
    View in: PubMed
    Score: 0.052
  10. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. 2020 08 06; 182(3):744-753.e4.
    View in: PubMed
    Score: 0.052
  11. Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody. J Virol. 2019 12 15; 93(24).
    View in: PubMed
    Score: 0.050
  12. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019 04 16; 50(4):907-923.
    View in: PubMed
    Score: 0.048
  13. Animal Models of Zika Virus Infection during Pregnancy. Viruses. 2018 10 31; 10(11).
    View in: PubMed
    Score: 0.046
  14. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature. 2018 05; 557(7706):570-574.
    View in: PubMed
    Score: 0.045
  15. Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections. Cell Rep. 2018 03 27; 22(13):3440-3453.e6.
    View in: PubMed
    Score: 0.044
  16. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J Exp Med. 2018 04 02; 215(4):1035-1045.
    View in: PubMed
    Score: 0.044
  17. Gestational Stage and IFN-? Signaling Regulate ZIKV Infection In Utero. Cell Host Microbe. 2017 Sep 13; 22(3):366-376.e3.
    View in: PubMed
    Score: 0.043
  18. Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease. Cell. 2017 Jul 13; 170(2):273-283.e12.
    View in: PubMed
    Score: 0.042
  19. Dengue Antibodies, then Zika: A Fatal Sequence in Mice. Immunity. 2017 05 16; 46(5):771-773.
    View in: PubMed
    Score: 0.042
  20. Vaccination strategies against Zika virus. Curr Opin Virol. 2017 04; 23:59-67.
    View in: PubMed
    Score: 0.042
  21. Animal Models of Zika Virus Infection, Pathogenesis, and Immunity. J Virol. 2017 04 15; 91(8).
    View in: PubMed
    Score: 0.041
  22. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 2017 03 09; 168(6):1114-1125.e10.
    View in: PubMed
    Score: 0.041
  23. Zika Virus Pathogenesis and Tissue Tropism. Cell Host Microbe. 2017 Feb 08; 21(2):134-142.
    View in: PubMed
    Score: 0.041
  24. The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses. J Virol. 2016 10 01; 90(19):8780-94.
    View in: PubMed
    Score: 0.040
  25. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 2012; 8(5):e1002698.
    View in: PubMed
    Score: 0.030
  26. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010 Nov 18; 468(7322):452-6.
    View in: PubMed
    Score: 0.027
  27. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol. 2006 Jul; 80(14):7009-19.
    View in: PubMed
    Score: 0.020
  28. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol. 2005 Jul; 79(14):8698-706.
    View in: PubMed
    Score: 0.018
  29. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003 Feb; 77(4):2578-86.
    View in: PubMed
    Score: 0.016
  30. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med. 2021 06 15; 2(6):100313.
    View in: PubMed
    Score: 0.014
  31. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 2021 04 15; 184(8):2229-2238.e13.
    View in: PubMed
    Score: 0.014
  32. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021 04 15; 184(8):2183-2200.e22.
    View in: PubMed
    Score: 0.014
  33. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe. 2021 03 10; 29(3):477-488.e4.
    View in: PubMed
    Score: 0.014
  34. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
    View in: PubMed
    Score: 0.014
  35. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 08; 584(7821):443-449.
    View in: PubMed
    Score: 0.013
  36. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol. 2020 08 15; 205(4):915-922.
    View in: PubMed
    Score: 0.013
  37. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020 05 13; 5(47).
    View in: PubMed
    Score: 0.013
  38. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope. Proc Natl Acad Sci U S A. 2019 01 29; 116(5):1591-1596.
    View in: PubMed
    Score: 0.012
  39. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice. Cell Host Microbe. 2018 11 14; 24(5):743-750.e5.
    View in: PubMed
    Score: 0.012
  40. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 2018 11 09; 362(6415):694-699.
    View in: PubMed
    Score: 0.012
  41. The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins. mSphere. 2018 09 19; 3(5).
    View in: PubMed
    Score: 0.011
  42. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice. J Virol. 2018 09 15; 92(18).
    View in: PubMed
    Score: 0.011
  43. Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice. J Virol. 2018 04 01; 92(7).
    View in: PubMed
    Score: 0.011
  44. Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability. Immunity. 2018 03 20; 48(3):487-499.e5.
    View in: PubMed
    Score: 0.011
  45. Zika virus-related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice. Sci Transl Med. 2018 01 31; 10(426).
    View in: PubMed
    Score: 0.011
  46. Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization. PLoS Pathog. 2017 Nov; 13(11):e1006743.
    View in: PubMed
    Score: 0.011
  47. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses. Cell Rep. 2017 Nov 07; 21(6):1600-1612.
    View in: PubMed
    Score: 0.011
  48. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
    View in: PubMed
    Score: 0.011
  49. Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med. 2017 Oct 02; 214(10):2843-2857.
    View in: PubMed
    Score: 0.011
  50. Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice. J Exp Med. 2017 Aug 07; 214(8):2303-2313.
    View in: PubMed
    Score: 0.011
  51. Plasmodium falciparum histidine-rich protein II causes vascular leakage and exacerbates experimental cerebral malaria in mice. PLoS One. 2017; 12(5):e0177142.
    View in: PubMed
    Score: 0.010
  52. MAVS Is Essential for Primary CD4+ T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection. J Virol. 2017 03 15; 91(6).
    View in: PubMed
    Score: 0.010
  53. A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLoS Pathog. 2017 02; 13(2):e1006178.
    View in: PubMed
    Score: 0.010
  54. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest. 2017 Mar 01; 127(3):843-856.
    View in: PubMed
    Score: 0.010
  55. Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice. Cell Host Microbe. 2017 Jan 11; 21(1):35-46.
    View in: PubMed
    Score: 0.010
  56. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol. 2011 Feb; 12(2):137-43.
    View in: PubMed
    Score: 0.007
  57. Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure. 2005 Jan; 13(1):75-85.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.